Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 3, 2006, Pages 1269-1281

  Zhao, YouYou ^a   Bell, David ^a   Smith, Lisa R ^a   Zhao, Li ^a   Devine, Adrian B ^a   McHenry, Eugene M ^a   Nicholls, D Paul ^b   McDermott, Barbara J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ALPHA ACTIN; BRAIN NATRIURETIC PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; H 1753; H 2910; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INTERMEDIN; INTERMEDIN RECEPTOR; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HYPERTENSION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR INTRINSIC ACTIVITY; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ADRENOMEDULLIN; ANIMALS; BODY WEIGHT; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; NEUROPEPTIDES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; ORGAN SIZE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PEPTIDE; RNA, MESSENGER; SYSTOLE;

EID: 33644781779     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.092783     Document Type: Article

References (40)

1. Autelitano DJ (1998) Cardiac expression of genes encoding putative adrenomedullin/calcitionin gene related peptide receptors. Biochem Biophys Res Commun 250:689-693.
2. Autelitano DJ and Ridings R (2001) Adrenomedullin signalling in cardiomyocytes is dependent upon CRLR and RAMP2 expression. Peptides 22:1851-1857.
3. Bartunek J, Weinberg EO, Tajima M, Rohrbach S, Katz SE, Douglas PS, and Lorell BH (2000) Chronic nitro-L-arginine methyl ester-induced hypertension: novel molecular adaptation to systolic load in absence of hypertrophy. Circulation 101:423-429.
4. Bayraktutan U, Yang ZK, and Shah AM (1998) Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat. Cardiovasc Res 38:719-726.
5. Bell D, Kelso EJ, Argent CC, Lee GR, Allen AR, and McDermott BJ (2004) Temporal dependence of the onset of parameters of cardiomyocyte hypertrophy in response to pressure overload in the spontaneously hypertensive rat. Cardiovascular Pathol 13:71-78.
6. Bell D and McDermott BJ (1994) CGRP stimulates a potent contractile response in rat ventricular cardiomyocytes by a cyclic AMP-independent mechanism. J Cardiovasc Pharmacol 23:1011-1021.
7. Bell D, Schluter KD, Zhou XJ, McDermott BJ, and Piper HM (1995) Hypertrophic effects of CGRP and amylin in adult mammalian ventricular cardiomyocytes. J Mol Cell Cardiol 27:2433-2443.
8. Bell D, Tamamori M, Marumo F, Hiroe M, McDermott BJ, and Ito H (1997) CGRP induces a fetal shift in gene expression in hypertrophying cardiomyocytes. Regul Pept 71:1-7.
9. Bell D, Zhao Y-Y, Kelso EJ, McHenry EM, Rush LM, Nicholls DP, and McDermott BJ (2006). Up-regulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis. Am J Physiol, in press.
10. Bernatova I, Pechanova O, and Simko F (1999) Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 84:1095-1105.
11. Chakravarty P, Suthar TP, Coppock HA, Nicholl CG, Bloom SR, Legon S, and Smith DM (2000) CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol 130:189-195.
12. Cueille C, Pidoux E, de Vernejoul M-C, Ventura-Clapier R, and Garel J-M (2002) Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. Biochem Biophys Res Commun 294:340-346.
13. De Oliveira CF, Nathan LP, Metze K, Moreno H Jr, de Luca IM, Sucupira M, Zatz R, Zappellini A, Antunes E, and de Nucci G (1999) Effect of calcium blockers on arterial hypertension and heart ischemic lesions induced by chronic blockade of nitric oxide in the rat. Eur J Pharmacol 373:195-200.
14. Franco-Cereceda A, Saria A, and Lundberg JM (1987) Ischemia and changes in contractility induce release of CGRP but nor NPY from the isolated perfused guinea-pig heart. Acta Physiol Scand 132:181-190.
15. Goto K, Fujii K, Onaka U, Abe I, and Fujishama M (2000) Renin-angiotensin system blockade improves endothelial dysfunction in hypertension. Hypertension 36:575-587.
16. Hampl V, Archer SL, Nelson DP, and Weir KE (1993) Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol 75:1748-1757.
17. Hua L, Li C, Xia D, Qu P, Li Z, Zhang W, and Feng X (2001) Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide. Hypertens Res 23:377-380.
18. Hay DL, Conner AC, Howitt SG, Smith DM, and Poyner DR (2004) The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 22:105-113.
19. Horio T, Nishikimi T, Yoshihara F, Nagaya N, Matsuo H, Takishita S, and Kangawa K (1998) Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1β and tumour necrosis factor-α. Endocrinology 139:4576-4580.
20. Ihara T, Ikeda U, Tate Y, Ishibashi S, and Shimada K (2000) Positive inotropic effects of adrenomedullin on rat papillary muscle. Eur J Pharmacol 390:167-172.
21. Ikenouchi H, Kangawa K, Matsuo H, and Hirata Y (1997) Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation 95:2318-2324.
22. Li YJ, Xiao ZS, Peng CF, and Deng HW (1996) Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts. Eur J Pharmacol 311:163-167.
23. Matsuoka H, Nakata M, and Kohno K (1996) Chronic L-arginine administration attenuates cardiac hypertrophy in SHR. Hypertension 27:14-18.
24. McLatchie LM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin receptor-like receptor. Nature (Lond) 393:333-339.
25. Mulderry PK, Ghatei MA, Rodrigo J, Allen JM, Rosenfeild MG, Polak JM, and Bloom SR (1985) CGRP in cardiovascular tissues of the rat. Neuroscience 14:947-954.
26. Nagaya N, Nishikimi T, Yoshihara F, Horio T, Morimoto A, and Kangawa K (2000) Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am J Physiol 278:R1019-R1026.
27. Nishikimi T, Horio T, Yoshihara F, Nagaya N, Matsuo H, and Kangawa K (1998) Effect of adrenomedullin on cyclic AMP and cyclic GMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol 353:337-344.
28. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, and Foord SM (2002) International Union of Pharmacology XXIII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev 54:233-246.
29. Prado MA, Evans-Bain B, Oliver KR, and Dickerson IM (2001) The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides 22:1773-1881.
30. Roh J, Chang CL, Bhalla A, Klein C, and Hsu SYT (2004) Intermedin is a calcitonin/calcitonin gene related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279:7264-7274.
31. Sabri A, Byron KL, Samarel AM, Bell J, and Lucchesi PA (1998) Hydrogen peroxide activates mitogen-activated protein kinases and Na/H exchange in neonatal rat cardiac myocytes. Circ Res 82:1053-1062.
32. Sarkar R, Webb RC, and Stanley JC (1995) Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery 118:274-279.
33. Sato A, Canny BJ, and Autelitano DJ (1997) Adrenomedullin stimulates cyclic AMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem Biophys Res Commun 230:311-314.
34. Siwik DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ, Singh K, Sawyer DB, and Colucci WS (1999) Inhibition of CuZn-SOD induces cell growth, hypertrophic phenotype and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 85:147-153.
35. Stauss HM, Godecke A, Mrowka R, and Schrader J (1999) Enhanced blood pressure variability in eNOS gene knockout mice. Hypertension 33:1359-1363.
36. Sumimoto T, Nishikimi T, Mukai M, Matsuzaki K, Murakami E, Takishita S, Miyata A, Matsuo H, and Kangawa K (1997) Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 30:741-745.
37. Takaori K, Kim S, Ohta K, Hamaguchi A, Yagi K, and Iwao H (1997) Inhibition nitric oxide synthase causes cardiac phenotypic modulation in rat. Eur J Pharmacol 322:59-62.
38. Taylor MM, Bagley SL, and Samson WK (2005) Intermedin/adrenomedullin-2 acts within the central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol 288:R919-R927.
39. Tsurada T, Kato J, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Komuro I, Yazaki Y, and Eto T (2000) Enhanced adrenomedullin production by mechanical stretching in cultured rat cardiomyocytes. Hypertension 35:1210-1214.
40. Willenbrock R, Langenickel T, and Knecht M (1999) Regulation of cardiac adrenomedullin mRNA in different stages of experimental heart failure. Life Sci 65:2241-2249.